• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

SEOM 临床指南：癌症患者化疗时止吐预防的治疗。

SEOM clinical guidelines for the treatment of antiemetic prophylaxis in cancer patients receiving chemotherapy.

机构信息

Servicio de Oncología Médica, Complejo Hospitalario de Orense, Orense, Spain.

出版信息

Clin Transl Oncol. 2010 Nov;12(11):770-4. doi: 10.1007/s12094-010-0594-5.

DOI:10.1007/s12094-010-0594-5
PMID:20974571
Abstract

Chemotherapy-induced emesis is one of the most frequent side effects that affect the quality of life of cancer patients undergoing chemotherapy. In recent years, clinical research has allowed us to increase our therapeutic arsenal with new drugs that have increased efficiency in the control of nausea and vomiting associated with chemo. This guide provides and update of the earlier published by our society and represents the continued commitment of SEOM to move forward and improve in the supportive care of cancer patients.

摘要

化疗引起的恶心呕吐是影响接受化疗的癌症患者生活质量的最常见副作用之一。近年来，临床研究使我们能够用新的药物来增加我们的治疗武器，这些药物提高了控制与化疗相关的恶心和呕吐的效率。本指南提供了我们协会之前发表的指南的更新，代表了 SEOM 不断致力于推进和改善癌症患者的支持性护理。

相似文献

1
SEOM clinical guidelines for the treatment of antiemetic prophylaxis in cancer patients receiving chemotherapy.SEOM 临床指南：癌症患者化疗时止吐预防的治疗。
Clin Transl Oncol. 2010 Nov;12(11):770-4. doi: 10.1007/s12094-010-0594-5.
2
SEOM Clinical Guideline update for the prevention of chemotherapy-induced nausea and vomiting (2016).SEOM化疗所致恶心和呕吐预防临床指南更新（2016年）
Clin Transl Oncol. 2016 Dec;18(12):1237-1242. doi: 10.1007/s12094-016-1583-0. Epub 2016 Nov 28.
3
SEOM guide to antiemetic prophylaxis in cancer patients treated with chemotherapy 2013.SEOM 癌症患者化疗止吐预防指南 2013 年版
Clin Transl Oncol. 2013 Dec;15(12):1030-6. doi: 10.1007/s12094-013-1093-2. Epub 2013 Sep 10.
4
A retrospective review of antiemetic use for chemotherapy-induced nausea and vomiting in pediatric oncology patients at a tertiary care center.对一家三级护理中心儿科肿瘤患者化疗引起的恶心和呕吐的止吐药使用情况进行回顾性研究。
J Oncol Pharm Pract. 2013 Jun;19(2):138-44. doi: 10.1177/1078155212457966. Epub 2012 Oct 3.
5
Comparative activity of antiemetic drugs.抗呕吐药物的比较活性。
Crit Rev Oncol Hematol. 2007 Feb;61(2):162-75. doi: 10.1016/j.critrevonc.2006.08.003.
6
Antiemesis clinical practice guidelines in oncology.肿瘤学中的止吐临床实践指南。
J Natl Compr Canc Netw. 2004 Sep;2(5):470-90. doi: 10.6004/jnccn.2004.0037.
7
Antiemetic prophylaxis in patients undergoing hematopoietic stem cell transplantation: a multicenter survey of the Gruppo Italiano Trapianto Midollo Osseo (GITMO) transplant programs.造血干细胞移植患者的止吐预防：意大利骨髓移植组（GITMO）移植项目的多中心调查。
Ann Hematol. 2020 Apr;99(4):867-875. doi: 10.1007/s00277-020-03945-3. Epub 2020 Feb 8.
8
ASCO, NCCN, MASCC/ESMO: a comparison of antiemetic guidelines for the treatment of chemotherapy-induced nausea and vomiting in adult patients.ASCO、NCCN、MASCC/ESMO：成人患者化疗所致恶心呕吐治疗止吐指南的比较。
Support Care Cancer. 2019 Jan;27(1):87-95. doi: 10.1007/s00520-018-4464-y. Epub 2018 Oct 3.
9
Delayed emesis induced by moderately emetogenic chemotherapy: do we need to treat all patients? The Italian Group for Antiemetic Research.中度致吐性化疗引起的延迟性呕吐：我们需要治疗所有患者吗？意大利止吐研究小组。
Ann Oncol. 1997 Jun;8(6):561-7.
10
2016 Updated MASCC/ESMO Consensus Recommendations: Controlling nausea and vomiting with chemotherapy of low or minimal emetic potential.2016年更新的MASCC/ESMO共识建议：控制低致吐或极低致吐风险化疗引起的恶心和呕吐
Support Care Cancer. 2017 Jan;25(1):297-301. doi: 10.1007/s00520-016-3391-z. Epub 2016 Aug 30.

引用本文的文献

1
NEPA, a new fixed combination of netupitant and palonosetron, is a cost-effective intervention for the prevention of chemotherapy-induced nausea and vomiting in the UK.奈帕（NEPA）是一种由奈妥吡坦和帕洛诺司琼组成的新型固定复方制剂，在英国是预防化疗引起的恶心和呕吐的一种具有成本效益的干预措施。
Drugs Context. 2017 Mar 24;6:212298. doi: 10.7573/dic.212298. eCollection 2017.
2
SEOM Clinical Guideline update for the prevention of chemotherapy-induced nausea and vomiting (2016).SEOM化疗所致恶心和呕吐预防临床指南更新（2016年）
Clin Transl Oncol. 2016 Dec;18(12):1237-1242. doi: 10.1007/s12094-016-1583-0. Epub 2016 Nov 28.
3

本文引用的文献

1
Palonosetron plus dexamethasone versus granisetron plus dexamethasone for prevention of nausea and vomiting during chemotherapy: a double-blind, double-dummy, randomised, comparative phase III trial.帕洛诺司琼联合地塞米松与格拉司琼联合地塞米松预防化疗期间恶心和呕吐的双盲、双模拟、随机、对照III期试验
Lancet Oncol. 2009 Feb;10(2):115-24. doi: 10.1016/S1470-2045(08)70313-9. Epub 2009 Jan 8.
2
Chemotherapy-induced nausea and vomiting.化疗引起的恶心和呕吐。
N Engl J Med. 2008 Jun 5;358(23):2482-94. doi: 10.1056/NEJMra0706547.
3
Chemotherapy-induced nausea and vomiting: ESMO clinical recommendations for prophylaxis.
Randomized pharmacokinetic study comparing subcutaneous and intravenous palonosetron in cancer patients treated with platinum based chemotherapy.
比较皮下注射与静脉注射帕洛诺司琼在接受铂类化疗的癌症患者中的随机药代动力学研究。
PLoS One. 2014 Feb 27;9(2):e89747. doi: 10.1371/journal.pone.0089747. eCollection 2014.
4
Chemotherapy-induced nausea and vomiting: pathophysiology and therapeutic principles.化疗所致恶心和呕吐：病理生理学和治疗原则。
Clin Transl Oncol. 2012 Jun;14(6):413-22. doi: 10.1007/s12094-012-0818-y.
5
The relevance of the Spanish Society for Medical Oncology (SEOM)'s clinical oncology guidelines.西班牙医学肿瘤学会（SEOM）临床肿瘤学指南的相关性。
Clin Transl Oncol. 2010 Nov;12(11):707-8. doi: 10.1007/s12094-010-0582-9.
化疗引起的恶心和呕吐：ESMO预防临床建议
Ann Oncol. 2008 May;19 Suppl 2:ii110-2. doi: 10.1093/annonc/mdn105.
4
A phase III, double-blind, randomized trial of palonosetron compared with ondansetron in preventing chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy.一项关于帕洛诺司琼与昂丹司琼预防高度致吐性化疗后化疗引起的恶心和呕吐的III期双盲随机试验。
Ann Oncol. 2006 Sep;17(9):1441-9. doi: 10.1093/annonc/mdl137. Epub 2006 Jun 9.
5
American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006.美国临床肿瘤学会肿瘤学止吐指南：2006年更新版
J Clin Oncol. 2006 Jun 20;24(18):2932-47. doi: 10.1200/JCO.2006.06.9591. Epub 2006 May 22.
6
Comparison of an aprepitant regimen with a multiple-day ondansetron regimen, both with dexamethasone, for antiemetic efficacy in high-dose cisplatin treatment.阿瑞匹坦方案与多日使用昂丹司琼方案（均联合地塞米松）在高剂量顺铂治疗中抗呕吐疗效的比较。
Ann Oncol. 2006 Jun;17(6):1000-6. doi: 10.1093/annonc/mdl019. Epub 2006 Mar 8.
7
Clinical practice guidelines on antiemetics in oncology.肿瘤学中抗呕吐药物的临床实践指南。
Expert Rev Anticancer Ther. 2005 Dec;5(6):963-72. doi: 10.1586/14737140.5.6.963.
8
Efficacy and tolerability of aprepitant for the prevention of chemotherapy-induced nausea and emesis over multiple cycles of moderately emetogenic chemotherapy.阿瑞匹坦在多周期中度致吐性化疗中预防化疗引起的恶心和呕吐的疗效及耐受性
Cancer. 2005 Oct 1;104(7):1548-55. doi: 10.1002/cncr.21343.
9
Antiemetic efficacy of the neurokinin-1 antagonist, aprepitant, plus a 5HT3 antagonist and a corticosteroid in patients receiving anthracyclines or cyclophosphamide in addition to high-dose cisplatin: analysis of combined data from two Phase III randomized clinical trials.神经激肽-1拮抗剂阿瑞匹坦联合5-羟色胺3拮抗剂及皮质类固醇对接受蒽环类药物或环磷酰胺加用大剂量顺铂治疗患者的止吐疗效：两项III期随机临床试验合并数据的分析
Cancer. 2005 Aug 15;104(4):864-8. doi: 10.1002/cncr.21222.
10
Efficacy and tolerability of aprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients with breast cancer after moderately emetogenic chemotherapy.阿瑞匹坦预防中度致吐性化疗后乳腺癌患者化疗引起的恶心和呕吐的疗效及耐受性
J Clin Oncol. 2005 Apr 20;23(12):2822-30. doi: 10.1200/JCO.2005.09.050.